PSP Research »

Axsome Therapeutics shares owned by PSP Research

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $481k 2.8k 169.02

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Axsome Therapeutics

Vanguard Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
Wellington Management Company
FMR
Geode Capital Management
Deep Track Capital
State Street Corporation
Rtw Investments
Assenagon Asset Management
Nomura Asset Management International
Alethea Capital Management
Susquehanna International

View all funds holding Axsome Therapeutics